Atalay, Sabri Ucak, Hazal Albayrak Caglayan, Derya Arkali, Eren Abakay, Hilal Koc, Gokhan
Published in
International journal of STD & AIDS
The majority of people living with HIV in our country are younger men. However, limited data exist for the sexual health of these patients. Knowledge of the epidemiology in this population may improve health outcomes across the continuum of HIV care. The aim of this study was to determine the prevalence of erectile dysfunction (ED) and its associat...
Huson, Mischa Rokx, Casper
Published in
International journal of STD & AIDS
In low resource settings point of care ultrasound (POCUS) has proven value for the detection of opportunistic diseases in HIV, especially tuberculosis. Few studies have explored POCUS in people with HIV and potential opportunistic infections in resource affluent settings. We performed a prospective observational study in the Netherlands. Outpatient...
Lauscher, Paul Hanhoff, Nikola Valbert, Frederik Schewe, Knud Koegl, Christine Bickel, Markus Hoffmann, Christian Stephan, Christoph Pauli, Ramona Preis, Stefan
...
Published in
AIDS care
Delayed HIV diagnosis at advanced stages of disease remains common (33%-64%). This analysis of the multi-center FindHIV study including newly diagnosed HIV-infected adults in Germany, focused on the potential role of socio-demographic and psychological factors on late diagnosis (formerly "late presentation", AIDS diagnosis or CD4 cells
Ogai, Kazuhiro Nana, Benderli Christine Lloyd, Yukie Michelle Arios, John Paul Jiyarom, Boonyanudh Awanakam, Honore Esemu, Livo Forgu Hori, Aki Matsuoka, Ayaka Nainu, Firzan
...
Published in
Frontiers in Cellular and Infection Microbiology
The presence of pathogens and the state of diseases, particularly skin diseases, may alter the composition of human skin microbiome. HIV infection has been reported to impair gut microbiome that leads to severe consequences. However, with cutaneous manifestations, that can be life-threatening, due to the opportunistic pathogens, little is known whe...
White, Kevin S. Walker, Joshua A. Wang, John Autissier, Patrick Miller, Andrew D. Abuelezan, Nadia N. Burrack, Rachel Li, Qingsheng Kim, Woong-Ki Williams, Kenneth C.
...
Published in
Frontiers in Immunology
Despite effective antiretroviral therapy, HIV co-morbidities remain where central nervous system (CNS) neurocognitive disorders and cardiovascular disease (CVD)-pathology that are linked with myeloid activation are most prevalent. Comorbidities such as neurocogntive dysfunction and cardiovascular disease (CVD) remain prevalent among people living w...
Stab, Viktoria Stahl-Hennig, Christiane Ensser, Armin Richel, Elie Fraedrich, Kirsten Sauermann, Ulrike Tippler, Bettina Klein, Florian Burton, Dennis R Tenbusch, Matthias
...
Published in
Cell reports. Medicine
Neutralizing antibodies targeting HIV-1 Env have been shown to protect from systemic infection. To explore whether these antibodies can inhibit infection of the first cells, challenge viruses based on simian immunodeficiency virus (SIV) were developed that use HIV-1 Env for entry into target cells during the first replication cycle, but then switch...
Labhardt, Niklaus Daniel Brown, Jennifer Anne Sass, Nikita Ford, Nathan Rosen, Sydney
Published in
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
The World Health Organization recommends same-day initiation of antiretroviral therapy (ART) for all persons diagnosed with HIV and ready to start treatment. Evidence, mainly from randomized trials, indicates offering same-day ART increases engagement in care and viral suppression during the first year. In contrast, most observational studies using...
Pasqualotto, Alessandro C Lana, Daiane Dalla Godoy, Cassia S M Leitão, Terezinha do Menino Jesus Silva Bay, Monica B Damasceno, Lisandra Serra Soares, Renata B A Kist, Roger Silva, Larissa R Wiltgen, Denusa
...
Published in
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Histoplasmosis is a major AIDS-defining illness in Latin America. Liposomal amphotericin B (L-AmB) is the drug of choice for treatment, but access is restricted due to the high drug and hospitalization costs of the conventional long regimens. Prospective randomized multicenter open-label trial of 1- or 2-dose induction therapy with L-AmB versus con...
Cuadros, Diego F Chowdhury, Tuhin Milali, Masabho Citron, Daniel T Nyimbili, Sulani Vlahakis, Natalie Savory, Theodora Mulenga, Lloyd Sivile, Suilanji Zyambo, Khozya Davie
...
Published in
BMJ global health
In sub-Saharan Africa, HIV/AIDS remains a leading cause of death. The UNAIDS established the '95-95-95' targets to improve HIV care continuum outcomes. Using geospatial data from the Zambia Population-based HIV Impact Assessment (ZAMPHIA), this study aims to investigate geospatial patterns in the '95-95-95' indicators and individual-level determina...
Martinez-Guerra, Bernardo A Valdez-Ventura, Rafael Caro-Vega, Yanink Sierra-Madero, Juan G Crabtree-Ramírez, Brenda E
Published in
AIDS care
Loss to follow-up (LTFU) and interruption of antiretroviral therapy (ART) are associated with worse outcomes in people with HIV (PWH). Little is known about gaps in the continuum of care. We conducted a retrospective cohort study including adult PWH with at least one clinical visit during 2000-2017. Three groups of care were defined: those constant...
